Moller San Pedro Claus Juan, Chief Executive Officer at Y-mAbs Therapeutics, Inc. (YMAB), bought 15,625 shares at $16.00 ($250K) on 2018-09-25, disclosed to the SEC on 2018-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.